Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Systematic Review and Meta-Analysis of Massive Suprachoroidal Hemorrhage

Tianyu Liu; Ayman G. Elnahry; Zujaja Tauqeer; Yinxi Yu; Gui-Shuang Ying; Benjamin J Kim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3398 – F0298. doi:

ARVO Annual Meeting Abstract June 2021

Clinical characteristics and treatment for dupilumab-related ocular complications in atopic dermatitis patients

Stephanie E. Jinno; Caroline W. Chung; Zujaja Tauqeer; Mina Massaro-Giordano; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1237. doi:

ARVO Annual Meeting Abstract June 2021

Glucagon-like peptide-1 receptor agonists are associated with decreased risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

Zujaja Tauqeer; Peter Bracha; Peiying Hua; Qi N Cui; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1122. doi:

ARVO Annual Meeting Abstract June 2020

Utility of hypercoagulable testing in young CRVO patients

Zujaja Tauqeer; Peter Bracha; Brendan McGeehan; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1303. doi:

ARVO Annual Meeting Abstract July 2018

Endophthalmitis Rates of Ranibizumab in Pre-Filled Syringes Compared to Vials

Zujaja Tauqeer; Philip Storey; Jeremy D. Wolfe; Bozho Todorich; Ankoor R Shah; Takashi Koto; Ashkan Abbey; Yuki Morizane; Karen Jeng-Miller; Eric Chen; Patrick Williams; Fumio Shiraga; Akito Hirakata; Sunir Garg; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5697. doi:

Advertisement